A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

NCT02392130 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Tissue Diseases
Connective Tissue Diseases

Interventions

DRUG: Clobetasol propionate 0.05% ointment
DRUG: LEO 130852A gel 1%
DRUG: LEO 130852A placebo gel

Sponsor

LEO Pharma